• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人实体瘤中的P-糖蛋白。表达及预后意义。

P-glycoprotein in adult solid tumors. Expression and prognostic significance.

作者信息

Leighton J C, Goldstein L J

机构信息

Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

出版信息

Hematol Oncol Clin North Am. 1995 Apr;9(2):251-73.

PMID:7642464
Abstract

Several potential mechanisms of chemotherapy resistance have been identified in adult solid tumors. The multidrug resistance (MDR) phenotype is one mechanism by which tumors may simultaneously develop resistance to multiple chemotherapeutic agents and is associated with P-glycoprotein expression. In this article, the authors examine the literature and summarize the various techniques used to measure MDR1 gene expression, patterns of expression in adult solid tumors.

摘要

在成人实体瘤中已确定了几种潜在的化疗耐药机制。多药耐药(MDR)表型是肿瘤可能同时对多种化疗药物产生耐药的一种机制,且与P-糖蛋白表达相关。在本文中,作者查阅了文献并总结了用于测量MDR1基因表达的各种技术以及成人实体瘤中的表达模式。

相似文献

1
P-glycoprotein in adult solid tumors. Expression and prognostic significance.成人实体瘤中的P-糖蛋白。表达及预后意义。
Hematol Oncol Clin North Am. 1995 Apr;9(2):251-73.
2
Multidrug resistance in pediatric malignancies.儿童恶性肿瘤中的多药耐药性。
Hematol Oncol Clin North Am. 1995 Apr;9(2):275-318.
3
Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.多药耐药性:实体瘤中的临床相关性及规避策略
Curr Opin Oncol. 1998 Aug;10 Suppl 1:S15-9.
4
Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.多药耐药相关蛋白P-糖蛋白、谷胱甘肽-S-转移酶、拓扑异构酶-II和肺耐药蛋白在原发性胃贲门腺癌中的表达
Cancer Invest. 2008 May;26(4):344-51. doi: 10.1080/07357900701788072.
5
Clinical studies with modulators of multidrug resistance.多药耐药调节剂的临床研究
Hematol Oncol Clin North Am. 1995 Apr;9(2):363-82.
6
The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.多药耐药转运蛋白在急性髓系白血病中的表达及功能的预后意义:西南肿瘤协作组白血病研究项目研究
Semin Hematol. 1997 Oct;34(4 Suppl 5):25-33.
7
In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides.mdr1反义寡脱氧核苷酸对人白血病耐药细胞系多药耐药性的体内外逆转作用
Cancer Res. 1996 Oct 1;56(19):4332-7.
8
Association of mdr1 gene expression with other prognostic factors and clinical outcome in human breast cancer.人乳腺癌中mdr1基因表达与其他预后因素及临床结局的关联
J Med Assoc Thai. 1997 Sep;80 Suppl 1:S162-73.
9
Expression of the human multidrug resistance gene (MDR1) and prognostic correlation in human osteogenic sarcoma.人多药耐药基因(MDR1)在人骨肉瘤中的表达及其预后相关性
Tokai J Exp Clin Med. 1994 Sep;19(1-2):39-46.
10
Drug resistance in clinical oncology and hematology. Introduction.临床肿瘤学和血液学中的耐药性。引言。
Hematol Oncol Clin North Am. 1995 Apr;9(2):xi-xii.

引用本文的文献

1
Prognostic gene expression signature revealed the involvement of mutational pathways in cancer genome.预后基因表达特征揭示了癌症基因组中突变途径的参与情况。
J Cancer. 2020 May 18;11(15):4510-4520. doi: 10.7150/jca.40237. eCollection 2020.
2
Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance.化疗药物刺激细胞外囊泡的释放和再循环,以帮助癌细胞产生紧急的化疗耐药性。
Mol Cancer. 2019 Dec 12;18(1):182. doi: 10.1186/s12943-019-1114-z.
3
Polymer-mediated gene therapy: Recent advances and merging of delivery techniques.
聚合物介导的基因治疗:最新进展和递送技术的融合。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Mar;12(2):e1598. doi: 10.1002/wnan.1598. Epub 2019 Dec 2.
4
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivo.免疫肿瘤药物 IPI-549 是一种调节 P-糖蛋白(P-gp,MDR1,ABCB1)介导的癌症多药耐药(MDR)的调节剂:体外和体内。
Cancer Lett. 2019 Feb 1;442:91-103. doi: 10.1016/j.canlet.2018.10.020. Epub 2018 Nov 1.
5
Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study.瑞戈非尼克服结直肠癌中由ABCB1转运蛋白介导的化疗多药耐药性:体外和体内研究
Cancer Lett. 2017 Jun 28;396:145-154. doi: 10.1016/j.canlet.2017.03.011. Epub 2017 Mar 14.
6
Synergistic Effect and Molecular Mechanisms of Traditional Chinese Medicine on Regulating Tumor Microenvironment and Cancer Cells.中药调控肿瘤微环境与癌细胞的协同效应及分子机制
Biomed Res Int. 2016;2016:1490738. doi: 10.1155/2016/1490738. Epub 2016 Mar 2.
7
Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistance.酪氨酸激酶抑制剂作为ABC转运蛋白介导的耐药逆转剂。
Molecules. 2014 Sep 4;19(9):13848-77. doi: 10.3390/molecules190913848.
8
Different modalities of intercellular membrane exchanges mediate cell-to-cell p-glycoprotein transfers in MCF-7 breast cancer cells.不同形式的细胞间膜交换介导 MCF-7 乳腺癌细胞中细胞间 P-糖蛋白的转移。
J Biol Chem. 2012 Mar 2;287(10):7374-87. doi: 10.1074/jbc.M111.312157. Epub 2012 Jan 6.
9
Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.多模态策略克服肿瘤药物耐药性:缺氧、瓦博格效应、干细胞和多功能纳米技术。
J Control Release. 2011 Oct 30;155(2):237-47. doi: 10.1016/j.jconrel.2011.03.032. Epub 2011 Apr 8.
10
Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning.缺氧和糖酵解在人肿瘤细胞多药耐药发展中的作用及应用低氧预处理建立裸鼠原位多药耐药肿瘤模型
Cancer Cell Int. 2011 Feb 14;11:3. doi: 10.1186/1475-2867-11-3.